Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients
Journal of Surgical Oncology, 05/04/2012Kato T et al.
CDC20 was a negative prognostic marker with significance in patients with resected non–small cell lung cancer (NSCLC), particularly those with ADC histology. These results provide additional information for determining postoperative adjuvant treatment.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.